Ampicillin Sodium

CHEMBL1200758 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

371.4 g/mol

LogP

—

Phase

4

The sodium salt form of ampicillin used for intravenous and intramuscular injection, providing rapid delivery of this beta-lactam antibiotic in hospital settings. It works by the same cell-wall disruption mechanism as oral ampicillin.

Peso molecular

371,4000 g/mol

TPSA

141,00 Å²

Áreas terapéuticas

Asma Cáncer colorrectal Cáncer de mama Cáncer de ovario Cáncer de páncreas Cáncer de próstata Cáncer de pulmón de células no pequeñas Cáncer de tiroides Cáncer de vejiga Degeneración macular relacionada con la edad Diabetes tipo 2 Dolor crónico Enfermedad cardiovascular Enfermedad del hígado graso no alcohólico Enfermedad de Parkinson Enfermedad infecciosa Enfermedad por reflujo gastroesofágico Enfermedad pulmonar obstructiva crónica Enfermedad renal crónica Enfermedad respiratoria Epilepsia Esquizofrenia Hipertensión Insomnio Insuficiencia cardíaca Leucemia Linfoma Malaria Manejo del dolor Migraña Obesidad Trastorno bipolar Trastorno de ansiedad generalizada Tuberculosis VIH/sida

Mecanismo de acción

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell …

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]

InChI

InChI=1S/C16H19N3O4S.Na/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8;/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23);/q;+1/p-1/t9-,10-,11+,14-;/m1./s1

Molecular Formula

C16H18N3NaO4S

HBD / HBA

2 / 6

Enlaces Rotables

4

Átomos Pesados

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The sodium salt form of ampicillin used for intravenous and intramuscular injection, providing rapid delivery of this beta-lactam antibiotic in hospital settings. It works by the same cell-wall disruption mechanism as oral ampicillin.

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Yes, Ampicillin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200758. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23663979. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Ampicillin Sodium en PillFYI

Estructura

Datos Rápidos

Fórmula: C16H18N3NaO4S
Sinónimos: 4

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.